Articles

Abstracted Scientific Content

Published on 29 May 2019

Regulatory requirements for the acceptance of foreign comparator products in the participants of the International Generic Drug Regulators Programme

Submitted: 4 March 2019; Revised: 25 April 2019; Accepted: 27 April 2019; Published online first: 30 April 2019 The availability of quality generic drug products plays an increasingly important role...

Author(s): Alfredo Garcรญa Arieta, PhD

DOI: 10.5639/gabij.2019.0801.005

15.445 views

Read more โ†’

Pharma News

Published on 21 May 2019

Top developments in biosimilars during 2018

Submitted: 5 February 2019; Revised: 14 March 2019; Accepted: 20 March 2019; Published online first: 2 April 2019 The global market for biosimilars is valued at approximately US$4 billion, and...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2019.0801.004

8.729 views

Read more โ†’

Published on 28 January 2019

2018/4 GaBI Journal Table of Contents

Contents Editorโ€™s Letter Fourth and final issue of GaBI Journalโ€™s seventh volume Editorial Nomenclature for biosimilars; a continuing thorny issue Original Research Ongoing activities to influence the prescribing of proton...

2.554 views

Read more โ†’

Editor's Letter

Published on 28 January 2019

Fourth and final issue of GaBI Journalโ€™s seventh volume

Globalization of the worldโ€™s economy has clearly created both major advances and ongoing challenges including in the pharmaceutical industry. Naming of pharmaceuticals might seem to be an uninteresting topic to...

Author(s): Professor Philip D Walson, MD

DOI: 10.5639/gabij.2018.0704.028

2.833 views

Read more โ†’

Published on 07 January 2019

2018/3 GaBI Journal Table of Contents

Contents Editorโ€™s Letter Latest features in GaBI Journal, 2018, Issue 3 Commentary Medicines regulation in the MENA region and the importance of the World Health Organizationโ€™s INN proposal of Biological...

2.284 views

Read more โ†’

Abstracted Scientific Content

Published on 19 December 2018

US generic prescription drug markets 2004โ€’2016

Submitted: 6 December 2018; Revised: 12 December 2018; Accepted: 14 December 2018; Published online first: 19 December 2018 Generic drugs are currently central to disease treatment in the US. However,...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2018.0704.033

6.316 views

Read more โ†’

Abstracted Scientific Content

Published on 03 December 2018

How does generic drug policy affect market prices?

Submitted: 21 November 2018; Revised: 22 November 2018; Accepted: 28 November 2018; Published online first: 4 December 2018 A study published by the World Health Organization (WHO) compares the effect...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2018.0703.027

5.186 views

Read more โ†’

Editor's Letter

Published on 03 December 2018

Latest features in GaBI Journal, 2018, Issue 3

This third issue of GaBI Journal in 2018 contains manuscripts which discuss a number of important, post-marketing, โ€˜real worldโ€™ generic and biosimilar medicinal product issues. In a Commentary, Pitts and...

Author(s): Professor Philip D Walson, MD

DOI: 10.5639/gabij.2018.0703.020

2.845 views

Read more โ†’

Thank you to reviewers

Published on 30 November 2018

Thank you to reviewers 2017

The editors and publisher wish to express their gratitude to the colleagues listed below for their valuable contribution to the peer review process for the Generics and Biosimilars Initiative Journal...

2.374 views

Read more โ†’

Published on 05 September 2018

2018/2 GaBI Journal Table of Contents

Contents Editorโ€™s Letter What to look forward to in GaBI Journal, 2018, Issue 2 Commentary Potential changes to the FDA approach to biosimilars have a global impact Original Research Patient-reported...

2.628 views

Read more โ†’

Editor's Letter

Published on 27 August 2018

What to look forward to in GaBI Journal, 2018, Issue 2

The second issue of the 2018 GaBI Journal volume is being published at a time of increasing uncertainty concerning trade, tariffs, regulations as well as international and even inter-ally co-operation....

Author(s): Professor Philip D Walson, MD

DOI: 10.5639/gabij.2018.0702.010

3.154 views

Read more โ†’

Abstracted Scientific Content

Published on 10 July 2018

EU risk-sharing agreements between 2000โˆ’2015

Submitted: 20 June 2018; Revised: 14 August 2018; Accepted: 18 August 2018; Published online first: 31 August 2018 The ageing population, longer life expectancies, and the increasing cost of drugs...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2018.0703.026

3.798 views

Read more โ†’